LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
22 hedge funds and large institutions have $6.15M invested in LAVA Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $5.99M → $6.15M (+$164K)
Holders
22
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$65.6K | |
| 2 | +$31.6K | |
| 3 | +$28K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$27.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$20.7K |
Top Sellers
| 1 | -$145K | |
| 2 | -$88.1K | |
| 3 | -$84.8K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$80K |
| 5 |
Two Sigma Advisers
New York
|
-$44.7K |